Amidst of all this, it is important to acknowledge the progress which has been made over the past decades.
Hi, I am Guy from Kieger.
Today, I want to focus on how quality of life has improved for HIV patients over the past thirty years.
Thanks to the tremendous advances in antiretroviral therapies, patients living with HIV are now living much longer than in the 90s.
This chart shows that in the US, the share of patients living to ages above 50 has increased from less than 15% to more than 50% between 1990 to 2019.
In part, this is due to more efficacious drugs which have a better safety profile. But this improvement also owes to the reduction of number of pills to take, which in turn improves compliance.
This illustrates how improving outcomes not only requires more efficacious drugs, but must also take patient behaviour into account.
What mattered this month in healthcare? The readout of the SELECT study was the single biggest healthcare event of the month. The results may open the door to wide reimbursement for GLP-1 weight-loss drugs. This led to an overreaction with significant price movements amongst many companies as markets just made blanket assumptions of a healthier, thinner world. Find out more in our monthly healthcare newsletter.
Remarkable Strides in Breast Cancer Survival: A Look at the Last Few Decades 🎗️📈 Intersted in knowing more? Check out Maria Specogna’s latest chart of the month video!
What mattered this month in healthcare? Second quarter earnings season kicked off to a strong start, with earnings overall better than estimates. However, positioning matters, and strong numbers were not always enough if expectations were high. Find out more in our monthly healthcare newsletter.